#### IV/PO model

Midazolam physicochemical properties and ADME parameters were incorporated from the model developed by Hanke, Frechen (5). Table 1. presents the drug specific parameters of midazolam and the values used within the healthy adult model.

The healthy PBPK model development by Hanke, Frechen (5) was based on PK studies by Hohmann, Kocheise (28), Hyland, Osborne (29), and Thummel, O'Shea (30).    


**Table 1. Physicochemical properties and ADME of midazolam for the final IV/PO model**

| **Physicochemical properties**    |                                      |
|--|--|
| Octanol:water coefficient (logP)           | 2.9 Log Units |
| Fraction unbound in plasma (f<sub>u</sub>) | 0.03 |
| Molecular weight (MW)                      | 325.78 g/mol |
| pKa                                        | 6.2 (base), 10.95 (acid) |
| Water solubility                           | 0.13 mg/mL |
| **ADME**                                   |                             |
| Partition coefficient                      | Rodgers and Rowland |
| Cell permeability                          | PK-Sim Standard |
| CYP3A4 concentration                       | 4.32 µM |
| CYP3A4 K<sub>M</sub>                       | 4 µM |
| CYP3A4 K<sub>cat</sub>                     | 8.76 1/min |
| UGT1A4 concentration                       | 2.32 µM |
| UGT1A4 K<sub>M</sub>                       | 37.8 µM |
| UGT1A4 K<sub>cat</sub>                     | 3.59 1/min |
| GFR                                        | 0.64 |
| Specific intestinal permeability (transcellular) | 1.44E-4 cm/min |
| **Oral absorption parameters**             |                             |
| Formulation: Tablet; Weibull dissolution time (50% dissolved), lag time, dissolution shape | 0.0107 min, 0 min, 4.38 |